SCHEMBL13737201

SCHEMBL13737201

Cc1cccc(-c2c(Cl)c(-c3ccccc3)nn2C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.43
MAPT P10636 4/20 0.43
LMNA P02545 2/20 0.43
TP53 P04637 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
MAPK1 P28482 1/20 0.42
CASP1 P29466 1/20 0.42
BRCA1 P38398 1/20 0.42
HTT P42858 1/20 0.42
CASP7 P55210 1/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
HSD17B10 Q99714 1/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 2/20 0.41
HPGD P15428 1/20 0.41
ALDH1A1 P00352 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13738449 0.94 TP53 (0.43) RECQLMAPTLMNATP53KMT2A
SCHEMBL13736647 0.85 RECQL (0.51) RECQLMAPTLMNAKMT2AMEN1
SCHEMBL13738541 0.84 TDP1 (0.51) RECQLMAPTLMNAKMT2AMEN1
SCHEMBL16200236 0.84 LMNA (0.44) MAPTLMNATP53NPC1RAB9A
SCHEMBL23400259 0.81 KMT2A (0.42) RECQLMAPTTP53KMT2AMEN1
SCHEMBL13737492 0.80 MAPT (0.57) MAPTLMNAHSD17B10SMN1; SMN2HPGD
SCHEMBL13736773 0.77 RECQL (0.39) RECQLMAPTKMT2AMEN1MAPK1
SCHEMBL13826497 0.76 PIK3CD (0.43) RECQLMAPTLMNAKMT2AMEN1
SCHEMBL13826210 0.76 PIK3CD (0.43) RECQLMAPTLMNAKMT2AMEN1
SCHEMBL16200060 0.76 THRB (0.52) RECQLMAPTLMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2701510-A1 PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME Usher III Initiative (US) 2014-03-05 EP disclosed
WO-2012148994-A1 PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME USHER III INITIATIVE (US) 2012-11-01 WO disclosed